In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Esperion Therapeutics Inc’s stock clocked out at $0.80, up 3.17% from its previous closing price of $0.78. In other words, the price has increased by $3.17 from its previous closing price. On the day, 4.94 million shares were traded.
Ratios:
To gain a deeper understanding of ESPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.81 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 17 ’25 when Warren Eric sold 108 shares for $0.98 per share. The transaction valued at 106 led to the insider holds 370,218 shares of the business.
Halladay Benjamin sold 8 shares of ESPR for $8 on Apr 17 ’25. The Chief Financial Officer now owns 481,702 shares after completing the transaction at $0.96 per share. On Apr 17 ’25, another insider, Halladay Benjamin, who serves as the Officer of the company, bought 8 shares for $0.96 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is -32.63%, while the 200-Day Moving Average is calculated to be -56.72%.
Shares Statistics:
A total of 196.66M shares are outstanding, with a floating share count of 194.72M. Insiders hold about 1.76% of the company’s shares, while institutions hold 59.21% stake in the company.
